0
ARTICLE |

LACTATION INHIBITION BY DELADUMONE INJECTED DURING LABOR OR JUST AFTER DELIVERY

Joseph B. Watrous, M.D.; Robert E. Ahearn, M.D.; Milton A. Carvalho, M.D.
JAMA. 1959;169(3):246-249. doi:10.1001/jama.1959.03000200044009.
Text Size: A A A
Published online

The course of postpartum changes in the breast was followed in 310 women who did not wish to breast feed their infants. A hormone preparation containing 90 mg. of testosterone enanthate and 4 mg. of estradiol valerate per cubic centimeter was injected parenterally in a single dose in each of 185 patients. These were compared with 83 patients who received a somewhat similar androgen-estrogen preparation in repeated doses by mouth and 42 who did not receive any hormone medication. Each patient was classified with respect to postpartum enlargement of breasts, signs of discomfort, and requirements of treatment with aspirin, binders, or ice caps. The incidence of engorgement among 268 hormone-treated patients was 8.3% as compared with 69% among 42 patients not so treated, and an equally marked difference was found in regard to postpartum breast pain. The parenteral medication, when injected in doses of 3 or 4 cc., was more effective than the oral medication, and a study of dosages and timing led to the conclusion that the most effective dosage of the parenteral preparation was a single injection of at least 3 cc. given preferably within the first hour post partum or at the end of the first stage of labor.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs